⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for tongue cancer

Every month we try and update this database with for tongue cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Correlation of FAZA PET Hypoxia Imaging To 3D Histology in Oral Tongue CancerNCT03181035
Tongue Cancer
(18)F-Fluoroazo...
Pimonidazole
18 Years - Sunnybrook Health Sciences Centre
Radiotherapy of Tongue Cancer Using an Intraoral StentNCT04337853
Tongue Cancer
Intraoral stent
No intraoral st...
18 Years - Oslo University Hospital
Cetuximab and Radiation Therapy in Treating Patients With Stage III-IV Head and Neck CancerNCT02177838
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage IV Squamo...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Tongue Cancer
cetuximab
cisplatin
external beam r...
laboratory biom...
18 Years - Rutgers, The State University of New Jersey
Ultrasound in Tongue Cancer- a Help to Decide Depth of Invasion and to Improve the Surgical MarginNCT04059861
Tongue Cancer
Floor of Mouth ...
Ultrasound
18 Years - Region Örebro County
Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue NeoplasiaNCT04534127
Skin Cancer
Mucosal Neoplas...
Soft Tissue Neo...
Radiation: Diff...
18 Years - Alpha Tau Medical LTD.
Dasatinib in Treating Patients With Recurrent or Metastatic Head and Neck CancerNCT00507767
Metastatic Squa...
Recurrent Metas...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Salivary Gland ...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
dasatinib
pharmacological...
laboratory biom...
18 Years - National Cancer Institute (NCI)
Direct Visual Fluorescence in Finding Oral Cancer in High-Risk Patients and Patients Undergoing Routine Dental CareNCT01816841
Lip and Oral Ca...
Oral Cavity Ver...
Stage 0 Lip and...
Tongue Cancer
fluorescence im...
biopsy
examination
Comparison of s...
18 Years - Ohio State University Comprehensive Cancer Center
Study of Blood and Tissue Samples From Patients With Larynx Cancer, Pharynx Cancer, or Oral Cavity CancerNCT00963326
Head and Neck C...
laboratory biom...
15 Years - National Cancer Institute (NCI)
S0420, Sorafenib in Treating Patients With Recurrent or Metastatic Head and Neck CancerNCT00096512
Metastatic Squa...
Recurrent Metas...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Salivary Gland ...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
Untreated Metas...
sorafenib tosyl...
laboratory biom...
18 Years - National Cancer Institute (NCI)
Retreatment With Intratumoral Diffusing Alpha Radiation EmittersNCT04540588
Skin Cancer
Mucosal Neoplas...
Soft Tissue Neo...
Radiation: Diff...
18 Years - Alpha Tau Medical LTD.
Surgical Margin Assessment by 3D UltrasoundNCT05740774
Tongue Cancer
Squamous Cell C...
Head and Neck C...
3D ultrasound
18 Years - Rigshospitalet, Denmark
Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 GeneNCT03602079
HER2-positive B...
HER2 Gene Mutat...
HER-2 Gene Ampl...
HER2 Positive G...
Salivary Gland ...
Salivary Gland ...
Salivary Gland ...
Salivary Gland ...
Lung Cancer
Colo-rectal Can...
Rare Diseases
Solid Tumor
Recurrent Gastr...
Recurrent Colon...
Recurrent Breas...
Head and Neck C...
Head and Neck C...
Bladder Cancer
Cervical Cancer
Liver Cancer
Bile Duct Cance...
Urologic Cancer
Pancreatic Canc...
Prostate Cancer
Recurrent Prost...
Rectal Cancer
Recurrent Ovari...
Recurrent Renal...
Rectal Cancer S...
Rectal Cancer S...
Rectal Cancer S...
Skin Cancer
Mouth Cancer
Lip Cancer Stag...
Tongue Cancer
Breast Neoplasm...
Larynx Cancer
Tonsil Cancer
Palate Cancer
Mucoepidermoid ...
Primary Periton...
Mucinous Adenoc...
Mucinous Breast...
Cholangiocarcin...
A166
18 Years - Klus Pharma Inc.
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072SNCT04430842
Astrocytoma
Brain Cancer
Brain Metastase...
Bladder Cancer
Breast Cancer
Cervical Cancer
Cholangiocarcin...
Colorectal Canc...
Esophagus Cance...
Gastric Cancer
Head and Neck C...
Kidney Cancer
Liver Cancer
Lung Cancer
Melanoma
Ovarian Cancer
Pancreatic Canc...
Pleural Mesothe...
Prostate Cancer
Sarcoma
Tongue Cancer
Thymic Carcinom...
Urinary Tract C...
QBS10072S
18 Years - Quadriga Biosciences, Inc.
Boronophenylalanine-Fructose Complex (BPA-F) and/or Sodium Borocaptate (BSH) Followed By Surgery in Treating Patients With Thyroid Cancer, Head and Neck Cancer, or Liver MetastasesNCT00062348
Colorectal Canc...
Head and Neck C...
Metastatic Canc...
boronophenylala...
sodium borocapt...
conventional su...
18 Years - European Organisation for Research and Treatment of Cancer - EORTC
Study of Blood and Tissue Samples From Patients With Larynx Cancer, Pharynx Cancer, or Oral Cavity CancerNCT00963326
Head and Neck C...
laboratory biom...
15 Years - National Cancer Institute (NCI)
Surgical Margin Assessment by 3D UltrasoundNCT05740774
Tongue Cancer
Squamous Cell C...
Head and Neck C...
3D ultrasound
18 Years - Rigshospitalet, Denmark
Measuring Patient Satisfaction With Facial Appearance: Development and Validation of a New Patient-Reported Outcome MeasureNCT00530049
Head and Neck C...
Psychosocial Ef...
questionnaire a...
assessment of t...
psychosocial as...
quality-of-life...
18 Years - Memorial Sloan Kettering Cancer Center
Sorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckNCT02035527
Metastatic Squa...
Recurrent Metas...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Salivary Gland ...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Oral ...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
Untreated Metas...
sorafenib tosyl...
cisplatin
docetaxel
Correlative Stu...
18 Years - Ohio State University Comprehensive Cancer Center
High-activity Natural Killer Immunotherapy for Small Metastases of Tongue CancerNCT03008330
Tongue Cancer
High-activity n...
30 Years - 60 YearsFuda Cancer Hospital, Guangzhou
Biomarkers in Tissue Samples From Patients Who Have Undergone Neck Dissection for Oral CancerNCT00899704
Head and Neck C...
microarray anal...
allele-specific...
diagnostic labo...
- Alliance for Clinical Trials in Oncology
Radiation Therapy and Cisplatin With or Without Surgery in Treating Patients With Stage III-IV Oropharyngeal CancerNCT01953952
Stage III Squam...
Stage IVA Squam...
Tongue Cancer
therapeutic con...
intensity-modul...
cisplatin
quality-of-life...
laboratory biom...
18 Years - Radiation Therapy Oncology Group
Nab-Paclitaxel, Cisplatin, and Cetuximab With Concurrent Radiation Therapy for Locally Advanced Head and Neck CancerNCT00851877
Head and Neck C...
Cetuximab
Cisplatin
Nab-Paclitaxel
intensity-modul...
18 Years - 120 YearsUniversity of Texas Southwestern Medical Center
Oral Stent Device for Radiation Treatments of Oral CancersNCT04041141
Tongue Tumor
Tongue Cancer
CT Scan
Experimental Or...
18 Years - Indiana University
Entolimod in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer Receiving Cisplatin and Radiation TherapyNCT01728480
Mucositis
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
entolimod
intensity-modul...
cisplatin
pharmacological...
laboratory biom...
18 Years - Roswell Park Cancer Institute
Nab-Paclitaxel, Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Recurrent Head and Neck CancerNCT00833261
Head and Neck C...
cetuximab
cisplatin
intensity-modul...
Nab-Paclitaxel
18 Years - 120 YearsUniversity of Texas Southwestern Medical Center
Dasatinib in Treating Patients With Recurrent or Metastatic Head and Neck CancerNCT00507767
Metastatic Squa...
Recurrent Metas...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Salivary Gland ...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
dasatinib
pharmacological...
laboratory biom...
18 Years - National Cancer Institute (NCI)
Cetuximab and Radiation Therapy in Treating Patients With Stage III-IV Head and Neck CancerNCT02177838
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage IV Squamo...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Tongue Cancer
cetuximab
cisplatin
external beam r...
laboratory biom...
18 Years - Rutgers, The State University of New Jersey
Photodynamic Therapy Using Temoporfin Before Surgery in Treating Patients With Recurrent Oral Cavity or Oropharyngeal CancerNCT01718223
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Stage I Squamou...
Stage I Squamou...
Stage I Verruco...
Stage II Squamo...
Stage II Squamo...
Stage II Verruc...
Tongue Cancer
photodynamic th...
therapeutic con...
laboratory biom...
temoporfin
18 Years - Roswell Park Cancer Institute
Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation TherapyNCT02123511
Mucositis
Oral Complicati...
Recurrent Adeno...
Recurrent Basal...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Mucoe...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Stage I Adenoid...
Stage I Basal C...
Stage I Lymphoe...
Stage I Lymphoe...
Stage I Mucoepi...
Stage I Salivar...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Verruco...
Stage I Verruco...
Stage II Adenoi...
Stage II Basal ...
Stage II Lympho...
Stage II Lympho...
Stage II Mucoep...
Stage II Saliva...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Verruc...
Stage II Verruc...
Stage III Adeno...
Stage III Basal...
Stage III Lymph...
Stage III Lymph...
Stage III Mucoe...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Lympho...
Stage IV Squamo...
Stage IVA Adeno...
Stage IVA Basal...
Stage IVA Lymph...
Stage IVA Mucoe...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Adeno...
Stage IVB Basal...
Stage IVB Lymph...
Stage IVB Mucoe...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Adeno...
Stage IVC Basal...
Stage IVC Lymph...
Stage IVC Mucoe...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
acetylcysteine
placebo
quality-of-life...
questionnaire a...
18 Years - Mayo Clinic
Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal VolunteersNCT00900419
Esophageal Canc...
Head and Neck C...
Lung Cancer
Precancerous Co...
immunohistochem...
laboratory biom...
sputum cytology
biopsy
21 Years - 90 YearsUniversity of Colorado, Denver
Induction Chemotherapy Followed By Cetuximab and Radiation in HPV-Associated Resectable Stage III/IV Oropharynx CancerNCT01084083
Head and Neck C...
Precancerous Co...
cetuximab
intensity-modul...
Paclitaxel
Cisplatin
18 Years - Eastern Cooperative Oncology Group
Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without ChemotherapyNCT01156142
Head and Neck C...
Mucositis
Oral Complicati...
Pain
doxepin hydroch...
placebo
18 Years - Alliance for Clinical Trials in Oncology
Acupuncture-Like Transcutaneous Electrical Nerve Stimulation (ALTENS) or Pilocarpine in Treating Early Dry Mouth in Patients Undergoing Radiation Therapy for Head and Neck CancerNCT00656513
Head and Neck C...
Xerostomia
Pilocarpine
ALTENS
18 Years - Radiation Therapy Oncology Group
Freeze-Dried Black Raspberries in Preventing Oral Cancer Recurrence in High At-Risk Appalachian Patients Oral Cancer SurvivorsNCT01504932
Stage I Squamou...
Stage I Squamou...
Stage I Verruco...
Stage II Squamo...
Stage II Squamo...
Stage II Verruc...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Tongue Cancer
BRB Lozenge
Survey Administ...
Laboratory Biom...
pharmacological...
21 Years - Ohio State University Comprehensive Cancer Center
Everolimus and Docetaxel in Treating Patients With Recurrent, Locally Advanced, or Metastatic Head and Neck CancerNCT01313390
Head and Neck C...
docetaxel
everolimus
laboratory biom...
pharmacological...
18 Years - University College, London
Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia.NCT03889899
Skin Cancer
Mucosal Neoplas...
Soft Tissue Neo...
Radiation: Diff...
18 Years - Alpha Tau Medical LTD.
Cetuximab and Combination Chemotherapy in Patients With Stage III-IV Resectable Oropharynx CancerNCT00665392
Head and Neck C...
cisplatin
docetaxel
fluorouracil
Cetuximab
18 Years - 75 YearsGERCOR - Multidisciplinary Oncology Cooperative Group
GM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Undergoing Radiation Therapy for Head and Neck CancerNCT00293462
Head and Neck C...
Mucositis Oral
Radiation Toxic...
Tongue Cancer
sargramostim
oral salt and s...
18 Years - University of California, San Francisco
Bowman-Birk Inhibitor Concentrate in Preventing Cancer in Patients With Oral LeukoplakiaNCT00330382
Lip and Oral Ca...
Oral Leukoplaki...
Oropharyngeal C...
Tongue Cancer
Bowman-Birk inh...
placebo
laboratory biom...
18 Years - National Cancer Institute (NCI)
Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer.NCT01469429
Metastatic Squa...
Salivary Gland ...
Stage 0 Hypopha...
Stage 0 Larynge...
Stage 0 Lip and...
Stage 0 Nasopha...
Stage 0 Orophar...
Stage 0 Paranas...
Stage I Salivar...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Verruco...
Stage I Verruco...
Stage II Saliva...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Verruc...
Stage II Verruc...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Oral ...
Stage IVA Squam...
Stage IVA Nasal...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Oral ...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Oral ...
Stage IVC Squam...
Paranasal Sinus...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
placebo
laboratory biom...
questionnaire a...
chemoprevention
chemoprevention
placebo
21 Years - Ohio State University Comprehensive Cancer Center
Lapatinib Ditosylate in Treating Patients With Metastatic or Recurrent Head and Neck CancerNCT00114283
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Salivary Gland ...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
lapatinib ditos...
laboratory biom...
18 Years - National Cancer Institute (NCI)
Erlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck CancerNCT00049283
Metastatic Squa...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
Untreated Metas...
erlotinib hydro...
docetaxel
radiation thera...
therapeutic con...
laboratory biom...
pharmacological...
18 Years - National Cancer Institute (NCI)
Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal and Superficial Soft Tissue Neoplasia (DaRT)NCT03886181
Skin Cancer
Mucosal Neoplas...
Soft Tissue Neo...
Device: Radiati...
18 Years - Alpha Tau Medical LTD.
Study of Nutrition Regimens in Treating Patients With Cancer of the Upper Aerodigestive TractNCT00765440
Head and Neck C...
Infection
Malnutrition
therapeutic nut...
placebo
18 Years - 75 YearsCentre Antoine Lacassagne
Erlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck CancerNCT00049283
Metastatic Squa...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
Untreated Metas...
erlotinib hydro...
docetaxel
radiation thera...
therapeutic con...
laboratory biom...
pharmacological...
18 Years - National Cancer Institute (NCI)
Phase II Randomized Trial of the Combination of Cetuximab and Sorafenib or Single Agent CetuximabNCT00939627
Metastatic Squa...
Recurrent Metas...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Salivary Gland ...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
Untreated Metas...
cetuximab
placebo
sorafenib tosyl...
laboratory biom...
quality-of-life...
18 Years - National Cancer Institute (NCI)
Celecoxib in Preventing Head and Neck Cancer in Patients With Oral LeukoplakiaNCT00101335
Head and Neck C...
Precancerous Co...
celecoxib
18 Years - Fox Chase Cancer Center
Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung CancerNCT02245100
Metastatic Squa...
Salivary Gland ...
Stage IIIA Non-...
Stage IIIB Non-...
Stage IV Non-sm...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
Untreated Metas...
Cytology specim...
Laboratory biom...
18 Years - Thomas Jefferson University
Quality-Of-Life Assessment in Patients With Head and Neck Cancer Treated With Radiation TherapyNCT01210872
Head and Neck C...
questionnaire a...
quality-of-life...
standard follow...
18 Years - 70 YearsNational Cancer Institute (NCI)
High-activity Natural Killer Immunotherapy for Small Metastases of Tongue CancerNCT03008330
Tongue Cancer
High-activity n...
30 Years - 60 YearsFuda Cancer Hospital, Guangzhou
Sunitinib, Cetuximab, and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Squamous Cell Carcinoma of the Head and NeckNCT00906360
Metastatic Squa...
Recurrent Metas...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Salivary Gland ...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
Tongue Cancer
Untreated Metas...
sunitinib malat...
pharmacological...
3-dimensional c...
cetuximab
18 Years - National Cancer Institute (NCI)
GM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Undergoing Radiation Therapy for Head and Neck CancerNCT00293462
Head and Neck C...
Mucositis Oral
Radiation Toxic...
Tongue Cancer
sargramostim
oral salt and s...
18 Years - University of California, San Francisco
Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal CancerNCT00397384
Adenocarcinoma ...
Adenocarcinoma ...
Advanced Adult ...
Carcinoma of th...
Gastrointestina...
Metastatic Gast...
Metastatic Squa...
Recurrent Adeno...
Recurrent Adult...
Recurrent Anal ...
Recurrent Basal...
Recurrent Colon...
Recurrent Esoph...
Recurrent Esthe...
Recurrent Extra...
Recurrent Gallb...
Recurrent Gastr...
Recurrent Gastr...
Recurrent Inver...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Metas...
Recurrent Midli...
Recurrent Mucoe...
Recurrent Non-s...
Recurrent Pancr...
Recurrent Recta...
Recurrent Saliv...
Recurrent Small...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Small Intestine...
Small Intestine...
Small Intestine...
Stage IV Adenoi...
Stage IV Anal C...
Stage IV Basal ...
Stage IV Colon ...
Stage IV Esopha...
Stage IV Esthes...
Stage IV Gastri...
Stage IV Invert...
Stage IV Lympho...
Stage IV Lympho...
Stage IV Midlin...
Stage IV Mucoep...
Stage IV Non-sm...
Stage IV Pancre...
Stage IV Rectal...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
Tongue Cancer
Unresectable Ex...
Unresectable Ga...
cetuximab
erlotinib hydro...
laboratory biom...
18 Years - National Cancer Institute (NCI)
Patient Preferences in Making Treatment Decisions in Patients With Stage I-IVA Oropharyngeal CancerNCT01949740
Stage I Squamou...
Stage II Squamo...
Stage III Squam...
Stage IVA Squam...
Tongue Cancer
questionnaire a...
quality-of-life...
18 Years - University of Chicago
Patient Preferences in Making Treatment Decisions in Patients With Stage I-IVA Oropharyngeal CancerNCT01949740
Stage I Squamou...
Stage II Squamo...
Stage III Squam...
Stage IVA Squam...
Tongue Cancer
questionnaire a...
quality-of-life...
18 Years - University of Chicago
Prosthesis Guided Speech Rehabilitation of T1/T2 Cancers of the TongueNCT02584270
Tongue Neoplasm...
Tongue Cancer
Oral Cancer
Palatal Augment...
Articulation Th...
18 Years - University of Michigan
Combination of Cryosurgey and NK Immunotherapy for Recurrent Tongue CancerNCT02849379
Recurrent Tongu...
Cryosurgery
NK immunotherap...
30 Years - 70 YearsFuda Cancer Hospital, Guangzhou
Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung CancerNCT00068497
Anaplastic Thyr...
Insular Thyroid...
Metastatic Para...
Recurrent Adeno...
Recurrent Basal...
Recurrent Esthe...
Recurrent Inver...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Metas...
Recurrent Midli...
Recurrent Mucoe...
Recurrent Non-s...
Recurrent Parat...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Thyro...
Recurrent Verru...
Stage III Folli...
Stage III Papil...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage IIIB Non-...
Stage IV Lympho...
Stage IV Non-sm...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Adeno...
Stage IVA Basal...
Stage IVA Esthe...
Stage IVA Folli...
Stage IVA Inver...
Stage IVA Lymph...
Stage IVA Midli...
Stage IVA Mucoe...
Stage IVA Papil...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Adeno...
Stage IVB Basal...
Stage IVB Esthe...
Stage IVB Folli...
Stage IVB Inver...
Stage IVB Lymph...
Stage IVB Midli...
Stage IVB Mucoe...
Stage IVB Papil...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Adeno...
Stage IVC Basal...
Stage IVC Esthe...
Stage IVC Folli...
Stage IVC Inver...
Stage IVC Lymph...
Stage IVC Midli...
Stage IVC Mucoe...
Stage IVC Papil...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Thryoid Gland N...
Thyroid Gland M...
Tongue Cancer
Untreated Metas...
gefitinib
- National Cancer Institute (NCI)
Entolimod in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer Receiving Cisplatin and Radiation TherapyNCT01728480
Mucositis
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
entolimod
intensity-modul...
cisplatin
pharmacological...
laboratory biom...
18 Years - Roswell Park Cancer Institute
Study of Nutrition Regimens in Treating Patients With Cancer of the Upper Aerodigestive TractNCT00765440
Head and Neck C...
Infection
Malnutrition
therapeutic nut...
placebo
18 Years - 75 YearsCentre Antoine Lacassagne
Cisplatin, Bevacizumab, and Intensity-Modulated Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck CancerNCT00423930
Head and Neck C...
bevacizumab
cisplatin
conventional su...
intensity-modul...
18 Years - Memorial Sloan Kettering Cancer Center
Everolimus and Docetaxel in Treating Patients With Recurrent, Locally Advanced, or Metastatic Head and Neck CancerNCT01313390
Head and Neck C...
docetaxel
everolimus
laboratory biom...
pharmacological...
18 Years - University College, London
Hypofractionated Radiation Therapy Followed by Surgery in Treating Patients With Advanced Squamous Cell Carcinoma of the Oral CavityNCT02295540
Stage III Squam...
Stage III Verru...
Stage IVA Squam...
Stage IVA Verru...
Stage IVB Squam...
Stage IVB Verru...
Tongue Cancer
hypofractionate...
intensity-modul...
therapeutic con...
laboratory biom...
18 Years - Rutgers, The State University of New Jersey
Chemotherapy, Radiation Therapy, and Cetuximab in Treating Patients With the Head and Neck CancerNCT00875849
Head and Neck C...
cetuximab
cisplatin
radiation thera...
18 Years - Centre Antoine Lacassagne
Cisplatin, Bevacizumab, and Intensity-Modulated Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck CancerNCT00423930
Head and Neck C...
bevacizumab
cisplatin
conventional su...
intensity-modul...
18 Years - Memorial Sloan Kettering Cancer Center
Rapamycin Therapy in Head and Neck Squamous Cell CarcinomaNCT01195922
Mouth Neoplasms
Head and Neck N...
Tongue Neoplasm...
Carcinoma, Squa...
Sirolimus
18 Years - 80 YearsNational Institutes of Health Clinical Center (CC)
Phase II Trial of Allovectin-7® for Head and Neck CancerNCT00050388
Head and Neck C...
Squamous Cell C...
Head and Neck N...
Carcinoma of th...
Allovectin-7®
18 Years - Vical
Dasatinib in Treating Patients With Recurrent or Metastatic Head and Neck CancerNCT00507767
Metastatic Squa...
Recurrent Metas...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Salivary Gland ...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
dasatinib
pharmacological...
laboratory biom...
18 Years - National Cancer Institute (NCI)
Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal and Superficial Soft Tissue Neoplasia (DaRT)NCT03886181
Skin Cancer
Mucosal Neoplas...
Soft Tissue Neo...
Device: Radiati...
18 Years - Alpha Tau Medical LTD.
Celecoxib in Preventing Head and Neck Cancer in Patients With Oral LeukoplakiaNCT00101335
Head and Neck C...
Precancerous Co...
celecoxib
18 Years - Fox Chase Cancer Center
Vaccine Therapy in Treating Patients With Head and Neck CancerNCT00404339
Head and Neck C...
mutant p53 pept...
tetanus toxoid ...
adjuvant therap...
18 Years - 120 YearsUniversity of Pittsburgh
Quality of Life in Patients Treated for Tongue and/or Jaw Neoplasia Before and After Speech TherapyNCT04126226
Tongue Cancer
Jaw Cancer
Oral Cancer
Intelligibility...
Speech-language...
Speech therapy ...
Speech therapy ...
18 Years - Hospital de Clinicas de Porto Alegre
Ixabepilone in Treating Patients With Metastatic or Recurrent Squamous Cell Cancer of the Head and NeckNCT00033618
Metastatic Squa...
Recurrent Metas...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Salivary Gland ...
Stage IV Squamo...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
ixabepilone
laboratory biom...
18 Years - National Cancer Institute (NCI)
Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer.NCT01469429
Metastatic Squa...
Salivary Gland ...
Stage 0 Hypopha...
Stage 0 Larynge...
Stage 0 Lip and...
Stage 0 Nasopha...
Stage 0 Orophar...
Stage 0 Paranas...
Stage I Salivar...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Verruco...
Stage I Verruco...
Stage II Saliva...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Verruc...
Stage II Verruc...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Oral ...
Stage IVA Squam...
Stage IVA Nasal...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Oral ...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Oral ...
Stage IVC Squam...
Paranasal Sinus...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
placebo
laboratory biom...
questionnaire a...
chemoprevention
chemoprevention
placebo
21 Years - Ohio State University Comprehensive Cancer Center
18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis TherapyNCT01806675
Adult Giant Cel...
Adult Glioblast...
Adult Gliosarco...
Male Breast Can...
Metastatic Squa...
Recurrent Adeno...
Recurrent Adult...
Recurrent Basal...
Recurrent Colon...
Recurrent Esthe...
Recurrent Hypop...
Recurrent Inver...
Recurrent Laryn...
Recurrent Lip a...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Metas...
Recurrent Midli...
Recurrent Mucoe...
Recurrent Nasop...
Recurrent Non-s...
Recurrent Oroph...
Recurrent Pancr...
Recurrent Paran...
Recurrent Recta...
Recurrent Renal...
Recurrent Saliv...
Stage IIIA Brea...
Stage IIIA Non-...
Stage IIIB Brea...
Stage IIIB Non-...
Stage IIIC Brea...
Stage IV Breast...
Stage IV Non-sm...
Stage IV Pancre...
Stage IV Renal ...
Stage IVA Colon...
Stage IVA Recta...
Stage IVA Saliv...
Stage IVB Colon...
Stage IVB Saliv...
Stage IVC Saliv...
Tongue Cancer
Unspecified Adu...
18F-fludeoxyglu...
18F-FPPRGD2
18 Years - Stanford University
Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck Squamous Cell CancerNCT01316757
Metastatic Squa...
Recurrent Metas...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Salivary Gland ...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
Tongue Cancer
Untreated Metas...
cetuximab
paclitaxel
carboplatin
erlotinib hydro...
laboratory biom...
18 Years - Fox Chase Cancer Center
Everolimus, Carboplatin, and Paclitaxel in Locally Advanced Head and Neck Cancer That Cannot Be Removed by SurgeryNCT01333085
Head and Neck C...
carboplatin
RAD001
paclitaxel
18 Years - GERCOR - Multidisciplinary Oncology Cooperative Group
Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia (DaRT)NCT03737734
Skin Cancer
Mucosal Neoplas...
Soft Tissue Neo...
Radiation: Diff...
18 Years - Alpha Tau Medical LTD.
RT With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck CancerNCT00956007
Head and Neck C...
cetuximab
intensity-modul...
18 Years - Radiation Therapy Oncology Group
Measuring Patient Satisfaction With Facial Appearance: Development and Validation of a New Patient-Reported Outcome MeasureNCT00530049
Head and Neck C...
Psychosocial Ef...
questionnaire a...
assessment of t...
psychosocial as...
quality-of-life...
18 Years - Memorial Sloan Kettering Cancer Center
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: